Celtic Therapeutics Management L.L.L.P. was founded in 2007 by Stephen Evans-Freke and Dr. Peter B. Corr, as a successor firm to Celtic Pharma Management L.P. The Celtic Therapeutics private equity strategy is to acquire promising therapeutic products that have achieved proof of principle in human clinical studies. Celtic Therapeutics' in-house team of senior pharmaceutical development executives then establishes the clinical, manufacturing, regulatory and commercial strategies for the development of its products and oversees its execution. Upon achieving value enhancing milestones including completing Phase III pivotal studies, Celtic Therapeutics partners with major pharmaceutical companies for continued development and commercialization. Based in the U.S. Virgin Islands, Celtic Therapeutics has origination, acquisition and development operations in New York City and Lausanne, Switzerland.
| Website | http://www.celtictherapeutics.com |
| Revenue | $5.4 million |
| Employees | View employees |
| Address | 663 5th Ave Fl 7, New York City, New York 10022, US |
| Phone | +1 212-616-4000 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Amgen, Genentech, Regeneron, Gilead Sciences, Biogen, Novartis, AbbVie, Vertex Pharmaceuticals, Bristol Myers Squibb, AstraZeneca +48 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Celtic Therapeutics employee's phone or email?
Celtic Therapeutics Questions
The Celtic Therapeutics annual revenue was $5.4 million in 2026.
Celtic Therapeutics is based in New York City, New York.
The NAICS codes for Celtic Therapeutics are [3254, 32, 325].
The SIC codes for Celtic Therapeutics are [28, 283].
